Developer docs
API playgroundTry for free, no card

Search company profiles

Archeon

Full company profile

uuid000313s

Namestring
Archeon
Legal namestring
ARCHEON
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Archeon Medical (legal entity ARCHEON SAS) is a privately held French MedTech company headquartered in Besançon, France, founded in 2017. The company specializes in AI-powered ventilation feedback devices designed for real-time monitoring of manual ventilation parameters during CPR and emergency care. Its core product, EOlife, is a medical-grade device that connects between a Bag Valve Mask (BVM) and the patient to measure volume insufflated, tidal volume, ventilation frequency, and air leaks. The proprietary FlowSense sensor technology, combined with in-house AI algorithms that infer tidal volume from inspiratory and expiratory flow curves, underpins the product. A complementary training device, EOlife X, is sold for use on mannequins and patient simulators and integrates via Bluetooth with the EOlife Connect mobile application (iOS and Android) for performance analysis against ERC and AHA international guidelines.

The business model is a hardware-plus-consumables structure. Revenue is generated from one-time device sales (EOlife for clinical use and EOlife X for training) and recurring sales of single-use FlowSense sensors, which must be replaced after each clinical use or every three months in the training device. Go-to-market is a hybrid of direct enterprise sales (targeting EMS, firefighters, and hospitals) for the clinically certified EOlife and a global authorized distributor channel for the certification-free EOlife X. The company is a venture-backed startup, having closed a €5.5M Series A in March 2022 led by Daphni, Karot Capital, and Majycc Innovation Santé with Bpifrance participation, and a follow-on Bpifrance instrument in July 2024. As of November 2025, the company is mid-execution on its first US clinical program, with concurrent trials in Chicago, Portland, and St. Louis aimed at validating its tripling-of-survival-rate outcome for US regulatory submission. Customer concentration spans three primary verticals: Emergency Medical Services, Healthcare Training Institutions, and Hospitals, with European public funder support (European Commission, iLab, French Tech, INPI) reinforcing its institutional positioning.

Short descriptiontext

Archeon Medical is a French MedTech company developing AI-powered ventilation feedback devices (EOlife and EOlife X) that provide real-time monitoring of manual ventilation during CPR, serving EMS providers, firefighters, hospitals, and healthcare training institutions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBesançon, France
HQ citystring
Besançon
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical ventilation devices, CPR ventilation feedback, emergency medical equipment, manual ventilation monitoring, AI respiratory sensors
Industry3 codes
PRIMARYHLAHAGAC
Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHSABAKAD
Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers)
Home & Personal Services/Elder Care & In-Home Care Services/Medical Equipment & Home Mobility Support Services
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Ventilation Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Sales (EOlife)
TypeOne Time License
Description

Sale of EOlife, an AI-powered ventilation feedback device for clinical/emergency use. This is the primary medical device sold to first responders, EMS services, and healthcare providers for use during cardiac emergencies.

archeon-medical.com
2Training Device Sales (EOlife X)
TypeOne Time License
Description

Sale of EOlife X, a training version of the ventilation feedback device designed for CPR training on mannequins. Used by training institutions and EMS training centers.

archeon-medical.com
3Consumables (FlowSense Sensors)
TypeHardware Sales
Description

Single-use FlowSense sensors that must be replaced after each use (EOlife) or every 3 months (EOlife X). Revenue generated from ongoing consumable purchases by device customers.

archeon-medical.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1EOlife
Description

AI-powered ventilation feedback device for manual ventilation during CPR; a medical device intended for clinical use on adult patients.

archeon-medical.com
+2 more records
Core offering1 text field

Archeon Medical develops and sells AI-powered ventilation feedback devices (EOlife, EOlife X) that provide real-time monitoring of manual ventilation parameters—volume insufflated, tidal volume, ventilation frequency, and air leaks—during CPR and emergency medical care. The offering is complemented by the EOlife Connect mobile application for performance analysis and by proprietary single-use FlowSense sensors that form the recurring consumable revenue stream. Customers are emergency medical services, firefighters, hospitals, and CPR training institutions in France, the United States, and other international markets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Tripled survival rates with full neurological recovery in cardiac arrest care
+3 more records
Product overview1 text field

Archeon Medical offers a portfolio of AI-powered ventilation feedback devices and training solutions. The core product is EOlife, a medical device for real-time ventilation monitoring during CPR and emergency care. EOlife X is a training-specific version for mannequin-based CPR education. Both devices use proprietary AI algorithms to estimate tidal volume and analyze ventilation quality. The ecosystem is supported by the EOlife Connect mobile app for data synchronization and analysis, and proprietary FlowSense/FlowSense X sensors for ventilation measurement.

Product and service3 records
1EOlife
CategoryMedical Ventilation Device
Description

AI-powered medical ventilation feedback device that provides real-time monitoring of ventilation parameters (tidal volume, ventilation frequency, leaks) during CPR and emergency care. Designed for use by first responders on adult patients to improve survival rates in cardiac emergencies.

2EOlife X
CategoryCPR Training Device
Description

Ventilation feedback device designed for CPR training on mannequins or patient simulators. Unlike EOlife, EOlife X is for training only and includes Bluetooth data download capability, blind recording mode, and pediatric training mode. Compatible with all market balloons, masks, tracheal tubes, and supraglottic devices.

3EOlife Connect
CategoryMobile Application
Description

Mobile application (iOS/Android) that allows importing, analyzing, and monitoring manual ventilation performance during training sessions with EOlife X. Provides feedback on ventilation quality and compliance with international recommendations, analyzing ventilation rate, insufflated volume, tidal volume, and leaks.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

ZOLL is a leading resuscitation medical device company with CPR feedback technology (compression depth/rate via Real CPR Help) and is a natural competitor as Archeon extends feedback from compressions to ventilation. ZOLL serves the same EMS, fire, and hospital customer base globally.

TypeBroad incumbent
Description

Philips is a global leader in hospital ventilators, patient monitoring, and AEDs, serving EMS and hospital customers. Its integrated resuscitation/monitoring platforms represent a broad competitive threat to a niche ventilation feedback device like EOlife.

TypeDirect peer
Description

Laerdal is a dominant player in CPR training (Resusci Anne, QCPR) and resuscitation devices, including BVMs. It competes directly with EOlife X in the CPR training market and overlaps with EOlife in ventilation quality improvement initiatives.

TypeBroad incumbent
Description

Mindray is a major manufacturer of patient monitoring and life-science medical devices sold globally, including to EMS-adjacent hospital departments. It competes broadly in the clinical vital-signs monitoring category that includes ventilation parameters.

5Dräger
TypeBroad incumbent
Description

Dräger manufactures ICU and transport ventilators, patient monitoring, and anesthesia equipment for hospitals and EMS. Its ventilator and monitoring portfolio positions it as a broad incumbent whose products overlap with Archeon's clinical ventilation quality use case.

6Nihon Kohden
TypeEmerging player
Description

Nihon Kohden is a specialist in patient monitoring and EEG/cardiac output measurement with growing EMS exposure. Its real-time physiological monitoring focus aligns with Archeon's real-time ventilation feedback value proposition for emergency and critical care settings.

TypeBroad incumbent
Description

Intersurgical designs and manufactures airway management and anesthesia products, including BVMs and supraglottic airways, which are compatible with EOlife. As an incumbent airway supplier to EMS, it is a comparable channel participant in the ventilation workflow.

TypeDirect peer
Description

3B Scientific is a global provider of medical simulation and CPR training manikins (e.g., Resusci Anne family) used by healthcare training institutions — the same buyer segment that purchases EOlife X for ventilation technique training.

TypeBroad incumbent
Description

Stryker's emergency medical division (formerly Physio-Control) sells LIFEPAK defibrillators, CPR assist devices (LUCAS), and resuscitation accessories to EMS and hospitals — the same buyer base as Archeon, and a likely platform competitor for integrated CPR quality feedback.

TypeBroad incumbent
Description

Ambu is a major manufacturer of single-use BVMs and airway management devices used in the same EMS and clinical workflows where EOlife operates. As a BVM incumbent, Ambu could bundle ventilation feedback into its established product portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Archeon

Medical Ventilation Devicesarcheon-medical.com

Archeon Medical is a French MedTech company developing AI-powered ventilation feedback devices (EOlife and EOlife X) that provide real-time monitoring of manual ventilation during CPR, serving EMS providers, firefighters, hospitals, and healthcare training institutions.

What Archeon does

Archeon Medical (legal entity ARCHEON SAS) is a privately held French MedTech company headquartered in Besançon, France, founded in 2017. The company specializes in AI-powered ventilation feedback devices designed for real-time monitoring of manual ventilation parameters during CPR and emergency care. Its core product, EOlife, is a medical-grade device that connects between a Bag Valve Mask (BVM) and the patient to measure volume insufflated, tidal volume, ventilation frequency, and air leaks. The proprietary FlowSense sensor technology, combined with in-house AI algorithms that infer tidal volume from inspiratory and expiratory flow curves, underpins the product. A complementary training device, EOlife X, is sold for use on mannequins and patient simulators and integrates via Bluetooth with the EOlife Connect mobile application (iOS and Android) for performance analysis against ERC and AHA international guidelines.

The business model is a hardware-plus-consumables structure. Revenue is generated from one-time device sales (EOlife for clinical use and EOlife X for training) and recurring sales of single-use FlowSense sensors, which must be replaced after each clinical use or every three months in the training device. Go-to-market is a hybrid of direct enterprise sales (targeting EMS, firefighters, and hospitals) for the clinically certified EOlife and a global authorized distributor channel for the certification-free EOlife X. The company is a venture-backed startup, having closed a €5.5M Series A in March 2022 led by Daphni, Karot Capital, and Majycc Innovation Santé with Bpifrance participation, and a follow-on Bpifrance instrument in July 2024. As of November 2025, the company is mid-execution on its first US clinical program, with concurrent trials in Chicago, Portland, and St. Louis aimed at validating its tripling-of-survival-rate outcome for US regulatory submission. Customer concentration spans three primary verticals: Emergency Medical Services, Healthcare Training Institutions, and Hospitals, with European public funder support (European Commission, iLab, French Tech, INPI) reinforcing its institutional positioning.

Archeon firmographics

Firmographics
Name
Archeon
Legal name
ARCHEON
Website
https://archeon-medical.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Archeon Medical is a French MedTech company developing AI-powered ventilation feedback devices (EOlife and EOlife X) that provide real-time monitoring of manual ventilation during CPR, serving EMS providers, firefighters, hospitals, and healthcare training institutions.
Ownership category
akta.pro rank

Archeon industry classification

Industry
Product category
Medical Ventilation Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAGAC
Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHSABAKAD
Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers)
Home & Personal Services/Elder Care & In-Home Care Services/Medical Equipment & Home Mobility Support Services

Keywords

  • Medical ventilation devices
  • CPR ventilation feedback
  • Emergency medical equipment
  • Manual ventilation monitoring
  • AI respiratory sensors

Where Archeon is headquartered

Location

Headquarters

HQ city
Besançon
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Archeon business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Medical Device Sales (EOlife): Sale of EOlife, an AI-powered ventilation feedback device for clinical/emergency use. This is the primary medical device sold to first responders, EMS services, and healthcare providers for use during cardiac emergencies.
  2. Training Device Sales (EOlife X): Sale of EOlife X, a training version of the ventilation feedback device designed for CPR training on mannequins. Used by training institutions and EMS training centers.
  3. Consumables (FlowSense Sensors): Single-use FlowSense sensors that must be replaced after each use (EOlife) or every 3 months (EOlife X). Revenue generated from ongoing consumable purchases by device customers.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Archeon product offering

Product offering

Core offering

Archeon Medical develops and sells AI-powered ventilation feedback devices (EOlife, EOlife X) that provide real-time monitoring of manual ventilation parameters—volume insufflated, tidal volume, ventilation frequency, and air leaks—during CPR and emergency medical care. The offering is complemented by the EOlife Connect mobile application for performance analysis and by proprietary single-use FlowSense sensors that form the recurring consumable revenue stream. Customers are emergency medical services, firefighters, hospitals, and CPR training institutions in France, the United States, and other international markets.

Product overview

Archeon Medical offers a portfolio of AI-powered ventilation feedback devices and training solutions. The core product is EOlife, a medical device for real-time ventilation monitoring during CPR and emergency care. EOlife X is a training-specific version for mannequin-based CPR education. Both devices use proprietary AI algorithms to estimate tidal volume and analyze ventilation quality. The ecosystem is supported by the EOlife Connect mobile app for data synchronization and analysis, and proprietary FlowSense/FlowSense X sensors for ventilation measurement.

Differentiator

Problem solved

Functional benefit

Brands

  • EOlife: AI-powered ventilation feedback device for manual ventilation during CPR; a medical device intended for clinical use on adult patients.
  • EOlife X
  • EOlife Connect

Products and services

  • EOlife AI-powered medical ventilation feedback device that provides real-time monitoring of ventilation parameters (tidal volume, ventilation frequency, leaks) during CPR and emergency care. Designed for use by first responders on adult patients to improve survival rates in cardiac emergencies.
  • EOlife X Ventilation feedback device designed for CPR training on mannequins or patient simulators. Unlike EOlife, EOlife X is for training only and includes Bluetooth data download capability, blind recording mode, and pediatric training mode. Compatible with all market balloons, masks, tracheal tubes, and supraglottic devices.
  • EOlife Connect Mobile application (iOS/Android) that allows importing, analyzing, and monitoring manual ventilation performance during training sessions with EOlife X. Provides feedback on ventilation quality and compliance with international recommendations, analyzing ventilation rate, insufflated volume, tidal volume, and leaks.

Quantifiable outcome

  • Tripled survival rates with full neurological recovery in cardiac arrest care
  • +3 more outcomes

Companies that use Archeon

Customer profile

Segments3 records

Ideal customer profiles3 records

Archeon technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability3 records

Feature3 records

Archeon partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Archeon competitors and assessment

Company assessment

Direct peers

  • ZOLL Medical (Asahi Kasei): ZOLL is a leading resuscitation medical device company with CPR feedback technology (compression depth/rate via Real CPR Help) and is a natural competitor as Archeon extends feedback from compressions to ventilation. ZOLL serves the same EMS, fire, and hospital customer base globally.
  • Laerdal Medical: Laerdal is a dominant player in CPR training (Resusci Anne, QCPR) and resuscitation devices, including BVMs. It competes directly with EOlife X in the CPR training market and overlaps with EOlife in ventilation quality improvement initiatives.
  • 3B Scientific: 3B Scientific is a global provider of medical simulation and CPR training manikins (e.g., Resusci Anne family) used by healthcare training institutions — the same buyer segment that purchases EOlife X for ventilation technique training.

Broad incumbents

  • Philips: Philips is a global leader in hospital ventilators, patient monitoring, and AEDs, serving EMS and hospital customers. Its integrated resuscitation/monitoring platforms represent a broad competitive threat to a niche ventilation feedback device like EOlife.
  • Mindray: Mindray is a major manufacturer of patient monitoring and life-science medical devices sold globally, including to EMS-adjacent hospital departments. It competes broadly in the clinical vital-signs monitoring category that includes ventilation parameters.
  • Dräger: Dräger manufactures ICU and transport ventilators, patient monitoring, and anesthesia equipment for hospitals and EMS. Its ventilator and monitoring portfolio positions it as a broad incumbent whose products overlap with Archeon's clinical ventilation quality use case.
  • Intersurgical: Intersurgical designs and manufactures airway management and anesthesia products, including BVMs and supraglottic airways, which are compatible with EOlife. As an incumbent airway supplier to EMS, it is a comparable channel participant in the ventilation workflow.
  • Stryker (Physio-Control / Lucas): Stryker's emergency medical division (formerly Physio-Control) sells LIFEPAK defibrillators, CPR assist devices (LUCAS), and resuscitation accessories to EMS and hospitals — the same buyer base as Archeon, and a likely platform competitor for integrated CPR quality feedback.
  • Ambu: Ambu is a major manufacturer of single-use BVMs and airway management devices used in the same EMS and clinical workflows where EOlife operates. As a BVM incumbent, Ambu could bundle ventilation feedback into its established product portfolio.

Emerging players

  • Nihon Kohden: Nihon Kohden is a specialist in patient monitoring and EEG/cardiac output measurement with growing EMS exposure. Its real-time physiological monitoring focus aligns with Archeon's real-time ventilation feedback value proposition for emergency and critical care settings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Archeon social profiles

Digital presence

Archeon financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Archeon leadership team

Management profile

Number of profiles

Profiles2 records

Archeon funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Archeon M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Archeon

What does Archeon do?

Archeon Medical develops and sells AI-powered ventilation feedback devices (EOlife, EOlife X) that provide real-time monitoring of manual ventilation parameters—volume insufflated, tidal volume, ventilation frequency, and air leaks—during CPR and emergency medical care. The offering is complemented by the EOlife Connect mobile application for performance analysis and by proprietary single-use FlowSense sensors that form the recurring consumable revenue stream. Customers are emergency medical services, firefighters, hospitals, and CPR training institutions in France, the United States, and other international markets.

Is Archeon a public or private company?

Archeon is a private company. It is classified as venture growth investor backed and is currently operating.

When was Archeon founded?

Archeon was founded in 2017. It employs 11 to 50 people.

Where is Archeon based?

Archeon is headquartered in Besançon, France, in the Europe region.

How does Archeon make money?

Three revenue lines are on record. Medical Device Sales (EOlife) is the primary driver. The others are training Device Sales (EOlife X) and consumables (FlowSense Sensors).

Who are Archeon's main competitors?

Direct peers on record are ZOLL Medical (Asahi Kasei), Laerdal Medical and 3B Scientific. Broad incumbents are Philips, Mindray, Dräger, Intersurgical, Stryker (Physio-Control / Lucas) and Ambu. Nihon Kohden is listed as an emerging player.

Does Archeon have an API?

No public API is recorded for Archeon.

What industry is Archeon in?

Archeon's product category is Medical Ventilation Devices. Its primary akta.pro industry code is HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
VestbeeArcheon Medical lands $9M Series A to scale cardiac arrest ventilation technologyArcheon Medical raised $9 million in a Series A round led by Newfund through its HEKA fund. The company will use the funding to support clinical studies involving over 1,500 cardiac arrest patients across Europe and the US. The studies aim to generate further clinical evidence on its EOlife ventilation feedback system.Les EchosArrêts cardiaques : Archeon Medical se refinance pour déployer son dispositif intelligent aux Etats-UnisArcheon Medical raised €7.5 million in a Series A led by Newfund to fund clinical studies and commercial deployment of its EOlife device in the US. The Besançon-based medtech, which generates over half its revenue in the US, previously raised €5.5 million in 2022 and several million in 2024.EIN PresswireWest Shore Community College sets new standard in Paramedic training with EOlife X integrationWest Shore Community College integrated the EOlife X ventilation feedback device into its EMS and Fire Programs, making it a standard component of airway and resuscitation labs. The device provides real-time, objective feedback on ventilation performance, addressing the subjectivity of visual chest rise. The integration positions the college at the forefront of paramedicine training in Michigan.BioSpaceArcheon Medical: first responder study shows novel ventilation device triples survival rates without brain damage in cardiac arrest care - US clinical trials to followArcheon Medical announced the launch of three independent clinical trials in Chicago, Portland, and St. Louis to validate its EOlife ventilation feedback device, following promising results from a French field study of 166 out-of-hospital cardiac arrest patients that showed a tripling of 30-day survival with full neurological recovery. The French study, conducted by firefighters in the Doubs region, found 100% of survivors achieved full neurological recovery compared to conventional ventilation, with the company claiming the device could potentially prevent up to 50,000 deaths annually in the US where approximately 356,000 cardiac arrests occur each year with only a 5-12% survival rate. The US trials will test EOlife on over 1,000 patients across simulation and real-world emergency settings, with the device already FDA-cleared and CE-marked as the first device to quantify actual tidal volume reaching the lungs during CPR.BenzingaArcheon Completes a €5.5m Series A Financing Round to Become a Global Leader in Smart VentilationArcheon completed a €5.5 million Series A financing round led by Karot Capital, Majycc eSanté Invest, and Daphni, with support from ERDF and Bpifrance. The funds will accelerate access to North America and expand its medical ventilation devices, including the PulmonAIR emergency ventilator. The company aims to become a global leader in smart ventilation.FRENCHWEB.FR[Série A] IA : Archeon lève 5,5 millions d’euros pour simplifier les gestes de premiers secoursFrench MedTech startup Archeon has raised 5.5 million euros from Karot Capital, Majycc eSanté Invest, and public backers to expand its AI-driven ventilation device, EOlife. The company aims to deploy the technology in France and enter the US market to improve survival rates for cardiac arrest and respiratory distress patients.Business Wire BlogArcheon Completes a €5.5m Series A Financing Round to Become a Global Leader in Smart VentilationArcheon has successfully completed a €5.5 million Series A financing round, led by investment funds Karot Capital, Majycc eSanté Invest, and Daphni, announced in Besançon, France. This funding will facilitate Archeon’s expansion into new markets, particularly North America, and enhance its product offerings in medical ventilation. The company aims to revolutionize emergency ventilation through its innovative EOlife device and the upcoming PulmonAIR emergency ventilator.MassDeviceArcheon raises more than $6M for AI-powered ventilation techArcheon, a France-based medical technology company, completed a Series A financing round exceeding $6 million to accelerate market expansion and product development. The funds will support the rollout of its AI-powered ventilation devices, such as the EOlife and PulmonAIR units, into new markets including North America. This investment is backed by investors including Karot Capital, Majycc eSanté Invest, Daphni, Bpifrance, and the European Regional Development Fund.